Medical Letter on the CDC & FDA
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Letter on the CDC & FDA
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Burkholderia Pseudomallei
Schema developed for laboratory identification of Burkholderia pseudomallei
July 24th, 2005
A schema has been developed for the laboratory identification of Burkholderia pseudomallei. According to a study from Australia, "Limited experience and a lack of validated diagnostic reagents make Burkholderia pseudomallei, the cause of melioidosis, difficult to recognize in the diagnostic microbiology laboratory. "We compared three methods of confirming the identity of presumptive B. pseudomallei strains using a collection of Burkholderia species drawn from diverse geographic, clinical, and environmental sources." "The 95 isolates studied included 71 B. pseudomallei and 3 B....
Source: Medical Letter on the CDC & FDA (2005-07-24)
|
